Telix Pharmaceuticals TLX
NASDAQ TLX
$9.51 +0.25 (+2.70%)
At close: Oct 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Other Non-Current Assets (2023 - 2026)

Updated

Telix Pharmaceuticals' Other Non-Current Assets was $33.89 million in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Other Non-Current Assets (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Other Non-Current Assets at Telix Pharmaceuticals came in at $28.83 million, up 91.0% from the prior year.

  • In earlier years, Other Non-Current Assets was $15.09 million in the year ended Dec 31, 2024 and $277,000 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,291.64 Bn 1,265.26 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 662.42 Bn 582.28 Bn 17.30 Bn 15.10 Bn
3 AbbVie 513.81 Bn 486.97 Bn 12.70 Bn 10.73 Bn
4 Merck 361.05 Bn 361.05 Bn - -
5 Novartis Ag 307.31 Bn 280.88 Bn - 700.00 Mn
6 Astrazeneca 270.49 Bn 244.25 Bn 12.86 Bn -
7 Amgen 249.07 Bn 204.47 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 205.52 Bn 205.52 Bn - -
9 Pfizer 170.71 Bn 117.65 Bn 10.94 Bn 9.94 Bn
10 Telix Pharmaceuticals 3.22 Bn 2.18 Bn - 33.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.89 Mn
Dec 31, 2025 28.83 Mn
Dec 31, 2024 15.29 Mn
Dec 31, 2023 400,021.32
API Access

Telix Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TLX&period=max&api_key=YOUR_API_KEY